Treatment of late endophthalmitis associated with filtering blebs.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001623:Betamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D003023:Cloxacillin / Q000009:adverse effects; D009877:Endophthalmitis / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D005260:Female; D005672:Fusidic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use; D005901:Glaucoma / Q000601:surgery; D006801:Humans; D008297:Male; D008712:Methicillin / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D011183:Postoperative Complications; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy; D013997:Time Factors; D014792:Visual Acuity
D005839:Gentamicins; D005672:Fusidic Acid; D001623:Betamethasone; D011239:Prednisolone; D003023:Cloxacillin; D008712:Methicillin